Coherus Bio (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CHRS | AMGN | BMY | GILD | VRTX |
Company | Coherus Bio | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
Open | 2.32 | 284.22 | 53.00 | 72.92 | 420.30 |
High | 2.44 | 286.82 | 53.69 | 73.06 | 420.42 |
Low | 2.28 | 282.55 | 52.85 | 72.55 | 412.65 |
Last | 2.42 | 286.30 | 53.25 | 73.01 | 417.32 |
Change | +0.12 | +4.53 | +0.70 | +0.60 | -1.14 |
% Change | +5.22% | +1.61% | +1.33% | +0.83% | -0.27% |
Volume | 2,583,900 | 2,256,300 | 13,077,600 | 7,747,500 | 905,400 |
20-Day Average Volume | 3,131,790 | 3,134,110 | 20,769,045 | 7,477,905 | 1,045,085 |
Previous Close | 2.30 | 281.77 | 52.55 | 72.41 | 418.46 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 2.31 | 275.97 | 52.40 | 73.48 | 415.37 |
20-Day Raw Stochastic | 62.71% | 97.21% | 62.50% | 25.41% | 38.30% |
20-Day Relative Strength | 50.90% | 53.75% | 59.38% | 43.89% | 50.28% |
Weighted Alpha | -54.00 | +18.50 | -19.90 | -12.50 | +30.80 |
Today's Opinion | 24% Sell | 40% Buy | 8% Buy | 88% Sell | 56% Buy |
Previous Opinion | 72% Sell | 24% Buy | 8% Sell | 88% Sell | 56% Buy |
Last Month's Opinion | 40% Sell | 40% Buy | 56% Sell | 40% Sell | 100% Buy |
Performance | |||||
5-Days | |||||
%Chg | -2.42% since 03/20/24 | +4.85% since 03/20/24 | +2.64% since 03/20/24 | -1.31% since 03/20/24 | +1.26% since 03/20/24 |
Low | 2.26 on 03/25/24 | 274.39 on 03/21/24 | 51.52 on 03/22/24 | 72.11 on 03/26/24 | 412.19 on 03/22/24 |
High | 2.64 on 03/21/24 | 286.82 on 03/27/24 | 53.69 on 03/27/24 | 74.28 on 03/21/24 | 420.42 on 03/27/24 |
1-Month | |||||
%Chg | -7.63% since 02/27/24 | +2.80% since 02/27/24 | +5.42% since 02/27/24 | -0.01% since 02/27/24 | -3.16% since 02/27/24 |
Low | 2.05 on 03/14/24 | 268.17 on 03/15/24 | 50.28 on 02/29/24 | 71.92 on 02/29/24 | 406.97 on 03/15/24 |
High | 2.64 on 03/21/24 | 286.82 on 03/27/24 | 55.03 on 03/13/24 | 76.21 on 03/11/24 | 433.99 on 03/04/24 |
3-Month | |||||
%Chg | -10.04% since 12/27/23 | -0.08% since 12/27/23 | +3.98% since 12/27/23 | -9.16% since 12/27/23 | +2.27% since 12/27/23 |
Low | 1.92 on 02/05/24 | 268.17 on 03/15/24 | 47.58 on 02/06/24 | 71.37 on 02/16/24 | 403.43 on 01/02/24 |
High | 3.70 on 01/02/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
6-Month | |||||
%Chg | -39.04% since 09/27/23 | +6.44% since 09/27/23 | -8.02% since 09/27/23 | -3.36% since 09/27/23 | +19.35% since 09/27/23 |
Low | 1.43 on 11/10/23 | 249.70 on 10/31/23 | 47.58 on 02/06/24 | 71.37 on 02/16/24 | 341.85 on 10/03/23 |
High | 4.01 on 09/28/23 | 329.72 on 02/05/24 | 58.46 on 09/29/23 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
Key Statistics | |||||
Market Capitalization, $K | 272,768 | 153,433,600 | 107,924,920 | 90,903,080 | 107,797,104 |
Shares Outstanding, K | 112,714 | 535,919 | 2,026,759 | 1,245,077 | 258,308 |
Annual Sales | 257,240,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
Annual Net Income | -237,890,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
Last Quarter Sales | 91,520,000 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,517,700,000 |
Last Quarter Net Income | -79,650,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 968,800,000 |
60-Month Beta | 0.54 | 0.58 | 0.38 | 0.18 | 0.35 |
Per-Share Information | |||||
Most Recent Earnings | -0.62 on 03/13/24 | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
Latest Earnings Date | 05/13/24 | 04/25/24 | 04/25/24 | 04/25/24 | 05/06/24 |
Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 01/04/24 | 0.770 on 03/14/24 | N/A |
Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 15.11 | 7.01 | 10.78 | 31.14 |